Pfizer: Too Big to Fly?
Forbes in an article in its upcoming September 4 issue agrees with some of my assessements of Pfizer.
Here's what they write:
Too Big to Fly?
Matthew Herper 09.04.06
In his five years in the top job at Pfizer, Henry McKinnell built Lipitor into a $12 billion behemoth, the world's biggest drug. Now it could be a millstone for Jeffrey Kindler, who replaced him in late July. An appeals court just cropped a year off Lipitor's patent (it now lasts until 2010), and generics of rival Zocor are already siphoning off Lipitor sales (see chart). Pfizer says Lipitor's track record is "unmatched," but some analysts doubt the drug can hit its $13 billion goal for the year.